BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33567388)

  • 1. Machine-learning analysis of contrast-enhanced computed tomography radiomics predicts patients with hepatocellular carcinoma who are unsuitable for initial transarterial chemoembolization monotherapy: A multicenter study.
    Jin Z; Chen L; Zhong B; Zhou H; Zhu H; Zhou H; Song J; Guo J; Zhu X; Ji J; Ni C; Teng G
    Transl Oncol; 2021 Apr; 14(4):101034. PubMed ID: 33567388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma.
    Niu XK; He XF
    World J Gastroenterol; 2021 Jan; 27(2):189-207. PubMed ID: 33510559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical-radiomics predictors to identify the suitability of transarterial chemoembolization treatment in intermediate-stage hepatocellular carcinoma: A multicenter study.
    Wang DD; Zhang JF; Zhang LH; Niu M; Jiang HJ; Jia FC; Feng ST
    Hepatobiliary Pancreat Dis Int; 2023 Dec; 22(6):594-604. PubMed ID: 36456428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiomics Analysis Based on Contrast-Enhanced MRI for Prediction of Therapeutic Response to Transarterial Chemoembolization in Hepatocellular Carcinoma.
    Zhao Y; Wang N; Wu J; Zhang Q; Lin T; Yao Y; Chen Z; Wang M; Sheng L; Liu J; Song Q; Wang F; An X; Guo Y; Li X; Wu T; Liu AL
    Front Oncol; 2021; 11():582788. PubMed ID: 33868988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiomic Features of Multi-ROI and Multi-Phase MRI for the Prediction of Microvascular Invasion in Solitary Hepatocellular Carcinoma.
    Yang Y; Fan W; Gu T; Yu L; Chen H; Lv Y; Liu H; Wang G; Zhang D
    Front Oncol; 2021; 11():756216. PubMed ID: 34692547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation.
    Fang S; Lai L; Zhu J; Zheng L; Xu Y; Chen W; Wu F; Wu X; Chen M; Weng Q; Ji J; Zhao Z; Tu J
    Front Mol Biosci; 2021; 8():662366. PubMed ID: 34532340
    [No Abstract]   [Full Text] [Related]  

  • 7. Radiomics Analysis on Multiphase Contrast-Enhanced CT: A Survival Prediction Tool in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
    Meng XP; Wang YC; Ju S; Lu CQ; Zhong BY; Ni CF; Zhang Q; Yu Q; Xu J; Ji J; Zhang XM; Tang TY; Yang G; Zhao Z
    Front Oncol; 2020; 10():1196. PubMed ID: 32850345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral and peritumoral radiomics based on contrast-enhanced MRI for preoperatively predicting treatment response of transarterial chemoembolization in hepatocellular carcinoma.
    Zhao Y; Zhang J; Wang N; Xu Q; Liu Y; Liu J; Zhang Q; Zhang X; Chen A; Chen L; Sheng L; Song Q; Wang F; Guo Y; Liu A
    BMC Cancer; 2023 Oct; 23(1):1026. PubMed ID: 37875815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative CECT-based Radiomic Signature for Predicting the Response of Transarterial Chemoembolization (TACE) Therapy in Hepatocellular Carcinoma.
    Bai H; Meng S; Xiong C; Liu Z; Shi W; Ren Q; Xia W; Zhao X; Jian J; Song Y; Ni C; Gao X; Li Z
    Cardiovasc Intervent Radiol; 2022 Oct; 45(10):1524-1533. PubMed ID: 35896687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A radiomics nomogram for predicting transcatheter arterial chemoembolization refractoriness of hepatocellular carcinoma without extrahepatic metastasis or macrovascular invasion.
    Sheen H; Kim JS; Lee JK; Choi SY; Baek SY; Kim JY
    Abdom Radiol (NY); 2021 Jun; 46(6):2839-2849. PubMed ID: 33388805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive prediction of perineural invasion in intrahepatic cholangiocarcinoma by clinicoradiological features and computed tomography radiomics based on interpretable machine learning: a multicenter cohort study.
    Liu Z; Luo C; Chen X; Feng Y; Feng J; Zhang R; Ouyang F; Li X; Tan Z; Deng L; Chen Y; Cai Z; Zhang X; Liu J; Liu W; Guo B; Hu Q
    Int J Surg; 2024 Feb; 110(2):1039-1051. PubMed ID: 37924497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of initial objective response to drug-eluting beads transcatheter arterial chemoembolization for hepatocellular carcinoma using CT radiomics-based machine learning model.
    Zhang X; He Z; Zhang Y; Kong J
    Front Pharmacol; 2024; 15():1315732. PubMed ID: 38344175
    [No Abstract]   [Full Text] [Related]  

  • 13. CT Radiomics to Predict Macrotrabecular-Massive Subtype and Immune Status in Hepatocellular Carcinoma.
    Feng Z; Li H; Liu Q; Duan J; Zhou W; Yu X; Chen Q; Liu Z; Wang W; Rong P
    Radiology; 2023 Apr; 307(1):e221291. PubMed ID: 36511807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Radiomics Nomogram for Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma.
    Yang L; Gu D; Wei J; Yang C; Rao S; Wang W; Chen C; Ding Y; Tian J; Zeng M
    Liver Cancer; 2019 Oct; 8(5):373-386. PubMed ID: 31768346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting Survival Using Pretreatment CT for Patients With Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: Comparison of Models Using Radiomics.
    Kim J; Choi SJ; Lee SH; Lee HY; Park H
    AJR Am J Roentgenol; 2018 Nov; 211(5):1026-1034. PubMed ID: 30240304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical-Radiomic Analysis for Pretreatment Prediction of Objective Response to First Transarterial Chemoembolization in Hepatocellular Carcinoma.
    Chen M; Cao J; Hu J; Topatana W; Li S; Juengpanich S; Lin J; Tong C; Shen J; Zhang B; Wu J; Pocha C; Kudo M; Amedei A; Trevisani F; Sung PS; Zaydfudim VM; Kanda T; Cai X
    Liver Cancer; 2021 Feb; 10(1):38-51. PubMed ID: 33708638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiomics and machine learning based on preoperative MRI for predicting extrahepatic metastasis in hepatocellular carcinoma patients treated with transarterial chemoembolization.
    Peng G; Cao X; Huang X; Zhou X
    Eur J Radiol Open; 2024 Jun; 12():100551. PubMed ID: 38347937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Preoperative Microvascular Invasion in Hepatocellular Carcinoma Through Multidimensional Parameter Combination Modeling Based on Gd-EOB-DTPA MRI.
    Zhang HD; Li XM; Zhang YH; Hu F; Tan L; Wang F; Jing Y; Guo DJ; Xu Y; Hu XL; Liu C; Wang J
    J Clin Transl Hepatol; 2023 Apr; 11(2):350-359. PubMed ID: 36643030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting the Initial Treatment Response to Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma by the Integration of Radiomics and Deep Learning.
    Peng J; Huang J; Huang G; Zhang J
    Front Oncol; 2021; 11():730282. PubMed ID: 34745952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of Hepatocellular Carcinoma Response to Transcatheter Arterial Chemoembolization: A Real-World Study Based on Non-Contrast Computed Tomography Radiomics and General Image Features.
    Guo Z; Zhong N; Xu X; Zhang Y; Luo X; Zhu H; Zhang X; Wu D; Qiu Y; Tu F
    J Hepatocell Carcinoma; 2021; 8():773-782. PubMed ID: 34277508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.